Collegium Pharmaceutical (COLL) Gross Margin (2016 - 2026)

Collegium Pharmaceutical's Gross Margin history runs 11 years deep, the most recent figure standing at 60.59% for Q1 2026.

• In Q1 2026, Gross Margin rose 583.0% year-over-year to 60.59%; the TTM figure through Mar 2026 stood at 60.68% (down 1403.0% YoY), while the FY2025 annual figure was 59.35%, down 41.0% from the prior year.
• Gross Margin was 60.59% for Q1 2026 at Collegium Pharmaceutical, down from 62.49% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 1334.14% in Q1 2022 to a low of 38.41% in Q4 2022.
• Historically, Gross Margin has averaged 199.05% across 5 years, with a median of 58.75% in 2023.
• The sharpest annual moves came in 2022 and 2023: Gross Margin jumped 127076 bps in 2022, then sank 128067 bps in 2023.
• A 5-year view of Gross Margin shows it stood at 38.41% in 2022, then jumped by 65 bps to 63.19% in 2023, then decreased by 15 bps to 54.02% in 2024, then gained by 16 bps to 62.49% in 2025, then retreated by 3 bps to 60.59% in 2026.
• The last three Gross Margin figures came in at 60.59% (Q1 2026), 62.49% (Q4 2025), and 61.7% (Q3 2025), per Business Quant data.